{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:42:32Z","timestamp":1792222952185,"version":"4.4.0"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.crad.2026.107450","type":"journal-article","created":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T23:17:00Z","timestamp":1785453420000},"page":"107450","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Multiparametric gadoxetic acid\u2013enhanced magnetic resonance imaging (MRI) biomarkers demonstrate stage-dependent associations in chronic liver disease"],"prefix":"10.1016","volume":"101","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3030-6794","authenticated-orcid":false,"given":"F.","family":"I\u015f\u0131k","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4659-0628","authenticated-orcid":false,"given":"M.H.","family":"Yener","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.E.","family":"I\u015f\u0131kta\u015f","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5074-5620","authenticated-orcid":false,"given":"S.","family":"Sipahio\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-1209-7036","authenticated-orcid":false,"given":"M.E.","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Dursun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"\u00d6zt\u00fcrk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9483-8861","authenticated-orcid":false,"given":"F.","family":"Alper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.crad.2026.107450_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.jhep.2021.05.025","article-title":"EASL Clinical Practice Guidelines on non-invasive tests for evaluation of liver disease severity and prognosis \u2013 2021 update","volume":"75","author":"Berzigotti","year":"2021","journal-title":"J Hepatol"},{"issue":"11","key":"10.1016\/j.crad.2026.107450_bib2","doi-asserted-by":"crossref","first-page":"3532","DOI":"10.1007\/s00261-020-02779-x","article-title":"Quantification of liver function using gadoxetic acid-enhanced MRI","volume":"45","author":"Poetter-Lang","year":"2020","journal-title":"Abdominal Radiology"},{"issue":"12","key":"10.1016\/j.crad.2026.107450_bib3","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1007\/s00330-011-2228-x","article-title":"Signal profile on Gd-EOB-DTPA-enhanced MR imaging in non-alcoholic steatohepatitis and liver cirrhosis induced in rats: correlation with transporter expression","volume":"21","author":"Tsuda","year":"2011","journal-title":"Eur Radiol"},{"issue":"5","key":"10.1016\/j.crad.2026.107450_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0215752","article-title":"Influence of hepatic fibrosis and inflammation: correlation between histopathological changes and Gd-EOB-DTPA-enhanced MR imaging","volume":"14","author":"Verloh","year":"2019","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.crad.2026.107450_bib5","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1124\/dmd.110.032862","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent Gd-EOB-DTPA: role of human organic anion transporters","volume":"38","author":"Leonhardt","year":"2010","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"10.1016\/j.crad.2026.107450_bib6","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0022-3565(24)34879-7","article-title":"Hepatic uptake of the magnetic resonance imaging contrast agent gadoxetate by the organic anion transporting polypeptide Oatp1","volume":"290","author":"van Montfoort","year":"1999","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.crad.2026.107450_bib7","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/jmri.25518","article-title":"Hepatic gadoxetic acid uptake as a measure of diffuse liver disease: where are we?","volume":"45","author":"Ba-Ssalamah","year":"2017","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.crad.2026.107450_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep43347","article-title":"Gd-EOB-DTPA-enhanced MRI for evaluation of liver function: comparison between signal-intensity-based indices and T1 relaxometry","volume":"7","author":"Haimerl","year":"2017","journal-title":"Sci Rep"},{"issue":"5","key":"10.1016\/j.crad.2026.107450_bib9","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1007\/s00330-014-3536-8","article-title":"Imaging-based evaluation of liver function: comparison of 99mTc-mebrofenin hepatobiliary scintigraphy and Gd-EOB-DTPA-enhanced MRI","volume":"25","author":"Geisel","year":"2015","journal-title":"Eur Radiol"},{"issue":"12","key":"10.1016\/j.crad.2026.107450_bib10","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1016\/j.ejrad.2016.10.010","article-title":"Hepatobiliary phase images using gadolinium-ethoxybenzyl-diethylenetriamine penta-acetic acid-enhanced MRI as an imaging surrogate for the albumin\u2013bilirubin grading system","volume":"85","author":"Takatsu","year":"2016","journal-title":"Eur J Radiol"},{"issue":"1139","key":"10.1016\/j.crad.2026.107450_bib11","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20220370","volume":"95","author":"Wang","year":"2022","journal-title":"Br J Radiol"},{"issue":"12","key":"10.1016\/j.crad.2026.107450_bib12","doi-asserted-by":"crossref","first-page":"6600","DOI":"10.1007\/s00330-019-06182-z","article-title":"Inter- and intra-reader agreement for gadoxetic acid\u2013enhanced MRI parameter readings in patients with chronic liver diseases","volume":"29","author":"Beer","year":"2019","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.crad.2026.107450_bib13","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.surg.2020.04.041","article-title":"Hepatic uptake index in the hepatobiliary phase of gadolinium ethoxybenzyl diethylenetriamine penta acetic acid\u2013enhanced magnetic resonance imaging estimates functional liver reserve and predicts post-hepatectomy liver failure","volume":"168","author":"Donadon","year":"2020","journal-title":"Surgery"},{"issue":"1","key":"10.1016\/j.crad.2026.107450_bib14","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1148\/radiol.2019190734","article-title":"Does the functional liver imaging score derived from gadoxetic acid\u2013enhanced MRI predict outcomes in chronic liver disease?","volume":"294","author":"Bastati","year":"2020","journal-title":"Radiology"},{"issue":"7","key":"10.1016\/j.crad.2026.107450_bib15","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1007\/s00261-022-03557-7","article-title":"Determining the efficacy of functional liver imaging score (FLIS) obtained from gadoxetic acid-enhanced MRI in patients with chronic liver disease and liver cirrhosis: the relationship between Albumin-Bilirubin (ALBI) grade and FLIS","volume":"47","author":"Aslan","year":"2022","journal-title":"Abdom Radiol"},{"issue":"7","key":"10.1016\/j.crad.2026.107450_bib16","doi-asserted-by":"crossref","first-page":"4804","DOI":"10.1007\/s00330-020-07495-0","article-title":"Noninvasive diagnosis of portal hypertension using gadoxetate DCE-MRI of the liver and spleen","volume":"31","author":"Hectors","year":"2021","journal-title":"Eur Radiol"},{"issue":"3","key":"10.1016\/j.crad.2026.107450_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.amjms.2020.10.031","article-title":"CT-scan based liver and spleen volume measurement as a prognostic indicator for patients with cirrhosis","volume":"362","author":"Patel","year":"2021","journal-title":"Am J Med Sci"},{"issue":"3","key":"10.1016\/j.crad.2026.107450_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2022.100645","article-title":"CT-derived liver and spleen volume accurately diagnose clinically significant portal hypertension in patients with hepatocellular carcinoma","volume":"5","author":"Romero-Crist\u00f3bal","year":"2023","journal-title":"JHEP Reports"},{"issue":"12","key":"10.1016\/j.crad.2026.107450_bib19","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.3348\/kjr.2021.0348","article-title":"Liver-to-Spleen volume ratio automatically measured on CT predicts decompensation in patients with B viral compensated cirrhosis","volume":"22","author":"Kwon","year":"2021","journal-title":"Korean J Radiol"},{"issue":"1059","key":"10.1016\/j.crad.2026.107450_bib20","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20150896","article-title":"Morphometric changes in liver cirrhosis: aetiological differences correlated with progression","volume":"89","author":"Ozaki","year":"2016","journal-title":"Br J Radiol"},{"issue":"1","key":"10.1016\/j.crad.2026.107450_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13244-024-01727-3","article-title":"The impact of hepatic and splenic volumetric assessment in imaging for chronic liver disease: a narrative review","volume":"15","author":"Kutaiba","year":"2024","journal-title":"Insights Imaging"},{"issue":"1","key":"10.1016\/j.crad.2026.107450_bib22","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2214\/AJR.09.2601","article-title":"Advanced MRI methods for assessment of chronic liver disease","volume":"193","author":"Taouli","year":"2009","journal-title":"Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.crad.2026.107450_bib23","first-page":"13","article-title":"Quantitative liver MRI biomarkers: what the radiologist should know","volume":"11","author":"Mazzola","year":"2024","journal-title":"J Med Imaging Interv Radiol"},{"issue":"4","key":"10.1016\/j.crad.2026.107450_bib24","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s00330-004-2236-1","article-title":"Hepatobiliary contrast agents for contrast-enhanced MRI of the liver: properties, clinical development and applications","volume":"14","author":"Reimer","year":"2004","journal-title":"Eur Radiol"},{"issue":"2","key":"10.1016\/j.crad.2026.107450_bib25","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.jhep.2012.01.031","article-title":"Primovist, Eovist: what to expect?","volume":"57","author":"Van Beers","year":"2012","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.crad.2026.107450_bib26","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1148\/radiol.2018180753","article-title":"Quantitative assessment of liver function by using gadoxetic acid-enhanced MRI: hepatocyte uptake ratio","volume":"290","author":"Yoon","year":"2019","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.crad.2026.107450_bib27","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1148\/radiology.141.2.6974875","article-title":"Measurement of liver and spleen volume by computed tomography. Assessment of reproducibility and changes found following a selective distal splenorenal shunt","volume":"141","author":"Henderson","year":"1981","journal-title":"Radiology"},{"issue":"2","key":"10.1016\/j.crad.2026.107450_bib28","doi-asserted-by":"crossref","first-page":"185","DOI":"10.7326\/0003-4819-90-2-185","article-title":"Accurate measurement of liver, kidney, and spleen volume and mass by computerized axial tomography","volume":"90","author":"Heymsfield","year":"1979","journal-title":"Ann Intern Med"},{"issue":"6","key":"10.1016\/j.crad.2026.107450_bib29","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.2214\/ajr.181.6.1811615","article-title":"Estimating splenic Volume: sonographic measurements correlated with helical CT determination","volume":"181","author":"Yetter","year":"2003","journal-title":"Am J Roentgenol"},{"issue":"7","key":"10.1016\/j.crad.2026.107450_bib30","doi-asserted-by":"crossref","first-page":"5142","DOI":"10.1007\/s00330-023-09402-9","article-title":"Relative enhancement index can be used to quantify liver function in cirrhotic patients that undergo gadoxetic acid-enhanced MRI","volume":"33","author":"Eiras-Ara\u00fajo","year":"2023","journal-title":"Eur Radiol"},{"issue":"1112","key":"10.1016\/j.crad.2026.107450_bib31","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20190989","article-title":"Patterns of enhancement in the hepatobiliary phase of gadoxetic acid-enhanced MRI","volume":"93","author":"Hui","year":"2020","journal-title":"Br J Radiol"},{"issue":"8","key":"10.1016\/j.crad.2026.107450_bib32","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1016\/j.mri.2011.05.007","article-title":"Staging liver fibrosis by using liver-enhancement ratio of gadoxetic acid-enhanced MR imaging: comparison with aspartate aminotransferase-to-platelet ratio index","volume":"29","author":"Motosugi","year":"2011","journal-title":"Magn Reson Imaging"},{"issue":"12","key":"10.1016\/j.crad.2026.107450_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2024.101209","article-title":"Use of artificial intelligence for liver diseases: a survey from the EASL congress 2024","volume":"6","author":"\u017digutyt\u0117","year":"2024","journal-title":"JHEP Reports"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026002278?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926026002278?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T07:27:14Z","timestamp":1792222034000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926026002278"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":33,"alternative-id":["S0009926026002278"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2026.107450","relation":{},"ISSN":["0009-9260"],"issn-type":[{"value":"0009-9260","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multiparametric gadoxetic acid\u2013enhanced magnetic resonance imaging (MRI) biomarkers demonstrate stage-dependent associations in chronic liver disease","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2026.107450","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Royal College of Radiologists. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"107450"}}